Drugs / Eperisone
Eperisone
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01869985 | Aug → Sep 2013 | — | Hanmi Pharmaceutical Company Limited | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT03424707 | Mar → Aug 2016 | — | Daewon Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT01806818 | Feb → Jul 2013 | — | Hanmi Pharmaceutical Company Limited | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT02040415 | Mar → Jul 2014 | — | Daewon Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT00327730 | Apr → Jun 2006 | — | Eisai Inc. | Completed | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 1 | NCT02289274 Comparator | Nov → Dec 2019 | — | NVP Healthcare | Withdrawn | No outcome recorded |
| Phase 3 | NCT01300312 Comparator | Feb → Jun 2011 | — | Eisai Inc. | Completed | No outcome recorded |
| — | NCT03337607 Comparator | Nov 2017 → Apr 2019 | — | First Affiliated Hospital of Zhejiang University | Completed | No outcome recorded |
Press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2024-03-29 | Eisai Inc. | EISAI TO DIVEST RIGHTS FOR MERISLON® AND MYONAL® IN JAPAN TO KAKEN PHARMACEUTICAL eisai.com ↗ |
| 2022-11-07 | Eisai Inc. | EISAI TO DIVEST RIGHTS FOR MUSCLE RELAXANT MYONAL® AND VERTIGO AND EQUILIBRIUM DISTURBANCE TREATMENT MERISLON® IN ASIA TO DKSH eisai.com ↗ |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Eperisone | “Comparing Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients” NCT01806818 ↗7“Eperisone Hydrochloride 50mg Tablet” NCT01869985 ↗ |
| Known as | DW-1030 | “DW-1030(eperisone HCl) 75mg” NCT02040415 ↗ |
| Known as | Eperisona | ChEMBL registry synonym — accepted as the source's own label CHEMBL1902981 ↗ |
| Known as | eperisone HCl | “DW-1030(eperisone HCl) 75mg” NCT02040415 ↗ |
| Known as | Myonal | “Patients will be treated with either Eperisone-HCl (Myonal) or placebo for a period of 14 days.” NCT00327730 ↗ |
| Known as | Myonal Tab. | “Myonal Tab.(eperisone HCl) 50mg” NCT02040415 ↗ |
| Modality | Small molecule | — CHEMBL1902981 ↗ |
| Route | Oral | “eperisone hydrochloride 50 mg as tablet formulation to be given 3 times daily after meals” NCT01300312 ↗ |